PDCD1 and cancer: Pathway analysis of these top immune-positive and -negative genes in each cancer type also revealed several well-known pathways associated with anti-PD1 response in some cancer types, such as the PI3K signaling, IFN-γ, and Wnt pathways (Supplementary Data 3a and 3b).